The non-canonical pathway receptor ROR1 is overexpressed in circulating tumor cells from pancreatic cancer patients and knockdown of ROR1 reduces invasiveness (Xu, Shen, Xu, Wang, & Ni, 2018). The gene discussed is ROR1; the disease is neoplasm.